IRIS

ARPINO, GRAZIA

ARPINO, GRAZIA  

DIPARTIMENTO DI MEDICINA CLINICA E CHIRURGIA  

Mostra records
Risultati 1 - 20 di 147 (tempo di esecuzione: 0.043 secondi).
Titolo Tipologia Data di pubblicazione Autore(i) File
Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance. 1.1 Articolo in rivista 2005 Arpino, Grazia; Weiss, H; Lee, Av; Schiff, R; DE PLACIDO, Sabino; Osborne, Ck; Elledge, R. M.
Idoxifene versus tamoxifen: a randomized comparison in postmenopausal patients with metastatic breast cancer. 1.1 Articolo in rivista 2003 Arpino, Grazia; M., Nair Krishnan; C., Doval Dinesh; V. J., Bardou; G. M., Clark; R. M., Elledge
Endocrine responsiveness: understanding how progesterone receptor can be used to select endocrine therapy. 1.1 Articolo in rivista 2005 C., Kent Osborne; Rachel, Schiff; Arpino, Grazia; Adrian Susan, Lee; V. G., Hilsenbeck
Treatment of human epidermal growth factor receptor 2-overexpressing breast cancer xenografts with multiagent HER-targeted therapy. 1.1 Articolo in rivista 2007 Arpino, Grazia; Carolina, Gutierrez; Heidi, Weiss; Mothaffar, Rimawi; Suleiman, Massarweh; Lavina, Bharwani; DE PLACIDO, Sabino; C., Kent Osborne; Rachel, Schiff
Prognostic and predictive factors in breast cancer, an evidence-based medicine approach 2.1 Contributo in volume (Capitolo o Saggio) 2002 Mohsin, Sk; Bardou, Vj; Arpino, Grazia; Chamness, Gc; Allred, Dc
Predictive value of apoptosis, proliferation, HER-2, and topoisomerase IIalpha for anthracycline chemotherapy in locally advanced breast cancer. 1.1 Articolo in rivista 2005 Arpino, Grazia; D. R., Ciocca; H., Weiss; D. C., Allred; P., Daguerre; L., Vargas Roig; M., Leuzzi; F., Gago; R., Elledge; S. K., Mohsin
Adenoid cystic carcinoma of the breast: molecular markers, treatment, and clinical outcome. 1.1 Articolo in rivista 2002 Arpino, Grazia; Gary M., Clark; Syed, Mohsin; Valerie J., Bardou; Richard M., Elledge
HER-2 amplification, HER-1 expression, and tamoxifen response in estrogen receptor-positive metastatic breast cancer: a southwest oncology group study. 1.1 Articolo in rivista 2004 Arpino, Grazia; Stephanie J., Green; D., Craig Allred; Dannika, Lew; Silvana, Martino; C., Kent Osborne; Richard M., Elledge
Hormone receptor status of a contralateral breast cancer is independent of the receptor status of the first primary in patients not receiving adjuvant tamoxifen. 1.1 Articolo in rivista 2005 Arpino, Grazia; H. L., Weiss; G. M., Clark; S. G., Hilsenbeck; C. K., Osborne
Progesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer databases. 1.1 Articolo in rivista 2003 Valerie Jeanne, Bardou; Arpino, Grazia; Richard M., Elledge; C., Kent Osborne; Gary M., Clark
Second-line chemotherapy with a hybrid-alternating regimen of bolus 5FU modulated by methotrexate and infusional 5FU modulated by folinic acid in patients with metastatic colorectal cancer pretreated with 5FU. A phase 2 study. 1.1 Articolo in rivista 2002 Carlomagno, Chiara; Lauria, Rossella; DE LAURENTIIS, Michelino; Arpino, Grazia; Massarelli, Erminia; Ferrara, Claudia; Milano, Andrea; Vernaglia, LOMBARDI ALESSANDRA; Costanzo, Raffaele; G., Catalano; Bianco, ANGELO RAFFAELE; DE PLACIDO, Sabino
A Metanalysis on the Interaction between HER2 Expression and Response to Endocrine Treatment in Advanced Breast Cancer 1.1 Articolo in rivista 2005 DE LAURENTIIS, Michelino; Arpino, Grazia; Massarelli, E; Ruggiero, A; Carlomagno, Chiara; Ciardiello, F; Tortora, G; D’Agostino, D; Caputo, F; Cancello, G; Montagna, E; Malorni, L; Zinno, L; Lauria, R; Bianco, Ar; DE PLACIDO, Sabino
Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy. 1.1 Articolo in rivista 2005 Xiaojiang, Cui; Rachel, Schiff; Arpino, Grazia; C., Kent Osborne; Adrian V., Lee
Lobular neoplasia on core-needle biopsy--clinical significance. 1.1 Articolo in rivista 2004 Arpino, Grazia; D., Craig Allred; Syed Khalid, Mohsin; Heidi L., Weiss; David, Conrow; Richard M., Elledge
Premalignant and in situ breast disease: biology and clinical implications. 1.1 Articolo in rivista 2005 Arpino, Grazia; Rodolfo, Laucirica; Richard M., Elledge
Health-care costs associated with breast cancer management 1.5 Abstract in rivista 2010 Cammarota, S.; Citarella, A.; Menditto, Enrica; Putignano, D.; Riegler, S.; De Luca, L.; Malorni, L.; DE PLACIDO, Sabino; Arpino, Grazia
A meta-analysis on the interaction between HER-2 expression and response to endocrine treatment in advanced breast cancer. 1.1 Articolo in rivista 2005 DE LAURENTIIS, Michelino; Arpino, Grazia; Massarelli, E; Ruggiero, A; Carlomagno, C; Ciardiello, F; Tortora, Giampaolo; D'Agostino, D; Caputo, F; Cancello, G; Montagna, E; Malorni, L; Zinno, L; Lauria, Rossella; Bianco, ANGELO RAFFAELE; DE PLACIDO, Sabino
SECOND-LINE CHEMOTHERAPY WITH A HYBRID-ALTERNATING REGIMEN OF BOLUS FLUOROURACIL MODULATED BY METHOTREXATE AND INFUSIONAL FLUOROURACIL MODULATED BY FOLINIC ACID IN PATIENTS WITH METASTATIC COLORECTAL CANCERPRETREATED WITH FLUOROURACIL. A PHASE II STUDY. 2.1 Contributo in volume (Capitolo o Saggio) 2002 Carlomagno, C; DE LAURENTIIS, Michelino; Lauria, R; Arpino, Grazia; Massarelli, E; Ferrara, C; Milano, A; VERNAGLIA LOMBARDI, A; Costanzo, R; Catalano, G; Bianco, Ar; DE PLACIDO, Sabino
GMO-Gestione Malattie Oncologiche in Regione Campania. 2.1 Contributo in volume (Capitolo o Saggio) 2011 Arpino, Grazia; Cammarota, Simona; DE ANGELIS, Carmine; Pizzi, Claudia; Perone, Vincenzo; Tommasielli, Giuseppina; Arpino, Giovanni; Novellino, Ettore; DE PLACIDO, Sabino
Capitolo 4 - Terapia Medica 2.1 Contributo in volume (Capitolo o Saggio) 2011 G., Tortora; F., Ciardiello; Arpino, Grazia; A. R., Bianco